NCT02335242View on ClinicalTrials.gov

Sildenafil for the Treatment of Lymphatic Malformations

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 23, 2015

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
Lymphatic MalformationsLymphatic Diseases
Interventions
DRUG

Sildenafil 20 mg tablets

OTHER

Placebo tablets (resembling Revatio)

Trial Locations (3)

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

94305

Stanford University, Stanford

80045-2571

University of Colorado, Denver, Aurora

All Listed Sponsors
collaborator

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

lead

Stanford University

OTHER

NCT02335242 - Sildenafil for the Treatment of Lymphatic Malformations | Biotech Hunter | Biotech Hunter